These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2578185)

  • 1. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR; Forno LS; Eng LF
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
    Emson PC; Arregui A; Clement-Jones V; Sandberg BE; Rossor M
    Brain Res; 1980 Oct; 199(1):147-60. PubMed ID: 6157454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
    Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
    Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
    Seizinger BR; Liebisch DC; Kish SJ; Arendt RM; Hornykiewicz O; Herz A
    Brain Res; 1986 Jul; 378(2):405-8. PubMed ID: 2873872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patients.
    de Ceballos ML; Fernandez A; Jenner P; Marsden CD
    Neurosci Lett; 1993 Oct; 160(2):163-6. PubMed ID: 7504224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study.
    Zech M; Bogerts B
    Acta Neuropathol; 1985; 68(1):32-8. PubMed ID: 2413707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.
    Clevens RA; Beal MF
    Brain Res; 1989 May; 486(2):387-90. PubMed ID: 2471578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration.
    Goto S; Hirano A; Matsumoto S
    Neurology; 1990 Jul; 40(7):1051-6. PubMed ID: 2192300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia.
    Zamir N; Skofitsch G; Bannon MJ; Helke CJ; Kopin IJ; Jacobowitz DM
    Brain Res; 1984 Nov; 322(2):356-60. PubMed ID: 6150750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.
    Fernandez A; de Ceballos ML; Rose S; Jenner P; Marsden CD
    Brain; 1996 Jun; 119 ( Pt 3)():823-30. PubMed ID: 8673494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P and substance P receptor histochemistry in human neurodegenerative diseases.
    Kowall NW; Quigley BJ; Krause JE; Lu F; Kosofsky BE; Ferrante RJ
    Regul Pept; 1993 Jul; 46(1-2):174-85. PubMed ID: 7692486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective effects of partial and severe lesions of the serotonergic systems on Met-enkephalin and substance P neurons in rat basal ganglia.
    Compan V; Salin P; Daszuta A
    Brain Res Mol Brain Res; 1997 Oct; 50(1-2):246-56. PubMed ID: 9406941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
    De Souza EB; Whitehouse PJ; Folstein SE; Price DL; Vale WW
    Brain Res; 1987 Dec; 437(2):355-9. PubMed ID: 2893655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene.
    O'Kusky JR; Nasir J; Cicchetti F; Parent A; Hayden MR
    Brain Res; 1999 Feb; 818(2):468-79. PubMed ID: 10082833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.